ArticleAntimicrobial agents and chemotherapy2013

GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.

Masayuki Amano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.